Literature DB >> 19242863

Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users.

Joseph Cox1, Carole Morissette, Prithwish De, Claude Tremblay, Robert Allard, Lisa Graves, Randolph Stephenson, Elise Roy.   

Abstract

Awareness of hepatitis C virus (HCV) infection status is expected to influence risk behaviors. In 2004-2005, injection drug users (IDUs) recruited from syringe exchange programs (SEPs) and methadone clinics in Montreal, Canada, were interviewed on drug use behaviors (past 6 months) and HCV testing. Subjects (n = 230) were classified as low/intermediate risk (20.4% borrowed drug preparation equipment only) and high risk (19.6% borrowed syringes), and 54.5% reported being HCV positive. Logistic regression modeling showed that compared to no risk (60% borrowed nothing), low/intermediate risk was associated with fewer noninjecting social network members, poor physical health, and problems obtaining sterile injecting equipment. High risk was associated with all of these factors except social networks. HCV status was not associated with any level of risk. Improved access to sterile injecting equipment may be more important than knowledge of HCV status in reducing injection risks among this IDU population. The study limitations are noted and recommendations discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19242863      PMCID: PMC2929254          DOI: 10.1080/10826080802544349

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  32 in total

1.  Screening for hepatitis C virus infection in adults: recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2004-03-16       Impact factor: 25.391

2.  The prevalence of additional injection-related HIV risk behaviors among injection drug users.

Authors:  S Koester; R E Booth; Y Zhang
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-06-01

3.  Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.

Authors:  M D Stein; J Maksad; J Clarke
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

Review 4.  A 'stages of change' approach to helping patients change behavior.

Authors:  G L Zimmerman; C G Olsen; M F Bosworth
Journal:  Am Fam Physician       Date:  2000-03-01       Impact factor: 3.292

5.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users.

Authors:  Carl A Latkin; Valerie Forman; Amy Knowlton; Susan Sherman
Journal:  Soc Sci Med       Date:  2003-02       Impact factor: 4.634

7.  Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs.

Authors:  Mark Davis; Tim Rhodes; Anthea Martin
Journal:  Soc Sci Med       Date:  2004-11       Impact factor: 4.634

Review 8.  NIH Consensus Statement on Management of Hepatitis C: 2002.

Authors: 
Journal:  NIH Consens State Sci Statements       Date:  2002 Jun 10-12

9.  The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users.

Authors:  Carol F Kwiatkowski; Karen Fortuin Corsi; Robert E Booth
Journal:  Addiction       Date:  2002-10       Impact factor: 6.526

10.  Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000.

Authors:  Catherine Hankins; Michel Alary; Raymond Parent; Caty Blanchette; Christiane Claessens
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-15       Impact factor: 3.731

View more
  13 in total

1.  HIV and HCV discordant injecting partners and their association to drug equipment sharing.

Authors:  Prithwish De; Joseph Cox; Jean-Francois Boivin; Robert W Platt; Ann M Jolly; Paul E Alexander
Journal:  Scand J Infect Dis       Date:  2009

2.  A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Authors:  T Spelman; M D Morris; G Zang; T Rice; K Page; L Maher; A Lloyd; J Grebely; G J Dore; A Y Kim; N H Shoukry; M Hellard; J Bruneau
Journal:  J Epidemiol Community Health       Date:  2015-03-26       Impact factor: 3.710

3.  Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.

Authors:  Patrick Habecker; Roberto Abadie; Melissa Welch-Lazoritz; Juan Carlos Reyes; Bilal Khan; Kirk Dombrowski
Journal:  Subst Use Misuse       Date:  2017-11-22       Impact factor: 2.164

4.  The case of a needle exchange policy debate in Fresno, California.

Authors:  Kris Clarke
Journal:  Crit Soc Policy       Date:  2015-10-05

5.  Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Authors:  Judith A Hahn; Jennifer L Evans; Peter J Davidson; Paula J Lum; Kimberly Page
Journal:  Addiction       Date:  2010-05-14       Impact factor: 6.526

6.  Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange.

Authors:  Prithwish De; Joseph Cox; Jean-François Boivin; Robert W Platt; Ann M Jolly
Journal:  J Urban Health       Date:  2007-11-24       Impact factor: 3.671

7.  Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.

Authors:  Judith I Tsui; Eric Vittinghoff; Judith A Hahn; Jennifer L Evans; Peter J Davidson; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2009-07-31       Impact factor: 4.492

8.  Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug users.

Authors:  Lauren E Cipriano; Gregory S Zaric; Mark Holodniy; Eran Bendavid; Douglas K Owens; Margaret L Brandeau
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  Current Rural Drug Use in the US Midwest.

Authors:  Kirk Dombrowski; Devan Crawford; Bilal Khan; Kimberly Tyler
Journal:  J Drug Abuse       Date:  2016-08-17

10.  Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Authors:  Meghan D Morris; Jennifer Evans; Martha Montgomery; Michelle Yu; Alya Briceno; Kimberly Page; Judith A Hahn
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.